Depression and sarcopenia: a Mendelian randomization analysis.
Journal
Psychiatric genetics
ISSN: 1473-5873
Titre abrégé: Psychiatr Genet
Pays: England
ID NLM: 9106748
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
21
7
2023
pubmed:
18
7
2023
entrez:
18
7
2023
Statut:
ppublish
Résumé
The association between depression and sarcopenia has been reported in observational studies but the causality of depression on sarcopenia remained unknown. We aimed to assess the causal effect between major depressive disorder (MDD) and sarcopenia using the two-sample Mendelian randomization (MR) method. A set of genetics instruments were used for analysis, derived from publicly available genetic summary data. Clinically, appendicular lean mass (ALM) and low hand grip strength (LHGS) have been widely used for the diagnosis of sarcopenia. Inverse-variance weighted method, weighted median method, MR-Egger, MR Pleiotropy RESidual Sum and Outlier test were used for the bidirectional MR analyses. No evidence for an effect of MDD on sarcopenia risk was found. MDD was not associated with ALM [effect = -0.17 (-0.60 to 0.27), P = 0.449] and LHGS [effect = 0.24 (-0.46 to 0.93), P = 0.506]. Sarcopenia was not associated with MDD [ALM: odds ratio (OR) = 0.999 (0.996-1.001), P = 0.374; LHGS: OR = 0.999 (0.996-1.002), P = 0.556]. MDD and Sarcopenia might mutually have no causal effect on each other.
Sections du résumé
BACKGROUND
The association between depression and sarcopenia has been reported in observational studies but the causality of depression on sarcopenia remained unknown. We aimed to assess the causal effect between major depressive disorder (MDD) and sarcopenia using the two-sample Mendelian randomization (MR) method.
METHODS
A set of genetics instruments were used for analysis, derived from publicly available genetic summary data. Clinically, appendicular lean mass (ALM) and low hand grip strength (LHGS) have been widely used for the diagnosis of sarcopenia. Inverse-variance weighted method, weighted median method, MR-Egger, MR Pleiotropy RESidual Sum and Outlier test were used for the bidirectional MR analyses.
RESULTS
No evidence for an effect of MDD on sarcopenia risk was found. MDD was not associated with ALM [effect = -0.17 (-0.60 to 0.27), P = 0.449] and LHGS [effect = 0.24 (-0.46 to 0.93), P = 0.506]. Sarcopenia was not associated with MDD [ALM: odds ratio (OR) = 0.999 (0.996-1.001), P = 0.374; LHGS: OR = 0.999 (0.996-1.002), P = 0.556].
CONCLUSION
MDD and Sarcopenia might mutually have no causal effect on each other.
Identifiants
pubmed: 37463392
doi: 10.1097/YPG.0000000000000346
pii: 00041444-202308000-00003
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
145-151Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Adachi H, Fujimoto K, Fujii A, Yamasaki K, Okada K, Matsuura T, et al. (2020). Long-term retrospective observation study to evaluate effects of adiponectin on skeletal muscle in renal transplant recipients. Sci Rep 10:10723.
Bao M, Chao J, Sheng M, Cai R, Zhang N, Chen H (2022). Longitudinal association between muscle strength and depression in middle-aged and older adults: a 7-year prospective cohort study in China. J Affect Disord 301:81–86.
Batsis JA, Villareal DT (2018). Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 14:513–537.
Bertoni M, Maggi S, Manzato E, Veronese N, Weber G (2018). Depressive symptoms and muscle weakness: a two-way relation? Exp Gerontol 108:87–91.
Bowden J, Davey Smith G, Burgess S (2015). Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512–525.
Burgess S, Thompson SG (2017). Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32:377–389.
Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. (2019). Guidelines for performing Mendelian randomization investigations. Wellcome Open Res 4:186.
Byeon CH, Kang KY, Kang SH, Kim HK, Bae EJ (2016). Sarcopenia is not associated with depression in Korean adults: results from the 2010-2011 Korean National Health and Nutrition Examination Survey. Korean J Fam Med 37:37–43.
Chang KV, Hsu TH, Wu WT, Huang KC, Han DS (2017). Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing 46:738–746.
Cruz-Jentoft AJ, Sayer AA (2019). Sarcopenia. Lancet 393:2636–2646.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al.; European Working Group on Sarcopenia in Older People (2010). Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. (2018). Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31.
Delibaş DH, Eşkut N, İlhan B, Erdoğan E, Top Karti D, Yilmaz Küsbeci O, et al. (2021). Clarifying the relationship between sarcopenia and depression in geriatric outpatients. Aging Male 24:29–36.
Eurelings LS, van Dalen JW, Ter Riet G, Moll VCE, Richard E, van Gool WA, et al. (2018). Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: a systematic review and meta-analysis of individual participant data. Clin Epidemiol 10:363–379.
Fan XX, Yuan J, Wei YJ, Zhou F, Xu L, Zhang Y, et al. (2020). Association between suicide risk severity and sarcopenia in non-elderly Chinese inpatients with major depressive disorder. BMC Psychiatry 20:345.
Gariballa S, Alessa A (2013). Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr 32:772–776.
Gariballa S, Alessa A (2020). Associations between low muscle mass, blood-borne nutritional status and mental health in older patients. BMC Nutr 6:6.
Hsu YH, Liang CK, Chou MY, Liao MC, Lin YT, Chen LK, et al. (2014). Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study. Geriatr Gerontol Int 14(Suppl 1):102–108.
Hwang AC, Liu LK, Lee WJ, Chen LY, Lin MH, Peng LN, et al. (2013). Association of androgen with skeletal muscle mass and muscle function among men and women aged 50 years and older in Taiwan: results from the I-Lan longitudinal aging study. Rejuv Res 16:453459.
Jones G, Trajanoska K, Santanasto AJ, Stringa N, Kuo CL, Atkins JL, et al. (2021). Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women. Nat Commun 12:654.
Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al.; 23andMe Research Team (2018). Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet 50:1112–1121.
Li N, Zhou R, Zhang B (2022a). Handgrip strength and the risk of major depressive disorder: a two-sample Mendelian randomisation study. Gen Psychiatr 35:e100807.
Li Z, Tong X, Ma Y, Bao T, Yue J (2022b). Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13:128–144.
Luigi FS, Matteo T, Francesca T, Grazia R (2022). Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: a systematic review and meta-analysis. medRxiv. doi: 10.1101/2022.07.01.22277107.
doi: 10.1101/2022.07.01.22277107
Maggio M, Lauretani F, Ceda GP (2013). Sex hormones and sarcopenia in older persons. Curr Opin Clin Nutr Metab Care 16:3–13.
Malhi GS, Mann JJ (2018). Depression. Lancet 392:2299–2312.
Milaneschi Y, Simmons WK, van Rossum E, Penninx BW (2019). Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry 24:18–33.
Moon JH, Kong MH, Kim HJ (2018). Low muscle mass and depressed mood in Korean adolescents: a cross-sectional analysis of the Fourth and Fifth Korea National Health and Nutrition Examination Surveys. J Korean Med Sci 33:e320.
Morley JE (2008). Sarcopenia: diagnosis and treatment. J Nutr Health Aging 12:452–456.
Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al. (2012). Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 21:223–242.
Pei YF, Liu YZ, Yang XL, Zhang H, Feng GJ, Wei XT, et al. (2020). The genetic architecture of appendicular lean mass characterized by association analysis in the UK Biobank study. Commun Biol 3:608.
Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, et al. (1999). Midlife hand grip strength as a predictor of old age disability. JAMA 281:558–560.
Roubenoff R, Castaneda C (2001). Sarcopenia-understanding the dynamics of aging muscle. JAMA 286:1230–1231.
Saccaro LF, Gasparini S, Rutigliano G (2022). Applications of Mendelian randomization in psychiatry: a comprehensive systematic review. Psychiatr Genet 32:199–213.
Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R (2010). Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75:35–41.
Sakuma K, Yamaguchi A (2012). Sarcopenia and age-related endocrine function. Int J Endocrinol 2012:10.
Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, et al.; Health ABC Study (2009). Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64:1183–1189.
United Nations Department of Economic and Social Affairs, Population Division (2022). World Population Prospects 2022: Summary of Results. UN DESA/POP/2022/TR/NO. 3.
Verbanck M, Chen CY, Neale B, Do R (2018). Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693–698.
Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. (2002). Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326–M332.
Wootton RE, Jones HJ, Sallis HM (2022). Mendelian randomisation for psychiatry: how does it work, and what can it tell us? Mol Psychiatry 27:53–57.
Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al.; eQTLGen (2018). Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50:668–681.
Yao S, Zhang M, Dong SS, Wang JH, Zhang K, Guo J, et al. (2022). Bidirectional two-sample Mendelian randomization analysis identifies causal associations between relative carbohydrate intake and depression. Nat Hum Behav 6:1569–1576.
Yuenyongchaiwat K, Buranapuntalug S, Pongpanit K, Kulchanarat C, Satdhabudha O (2020). Anxiety and depression symptomatology related to inspiratory muscle strength and functional capacity in preoperative cardiac surgery patients: a preliminary cross-sectional study. Indian J Psychol Med 42:549–554.
Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M (2009). Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 15:289–305.